Back
Compare AU
Compare DACE vs. HLTH
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Dimensional Australian Core Equity Trust - Active ETF (DACE) and the VanEck Global Healthcare Leaders ETF (HLTH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DACE | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 19 | 54 |
Median incremental investment | $2,446.75 | $547.55 |
Median investment frequency | Monthly | Monthly |
Median total investment | $10,858.89 | $1,541.09 |
Average age group | 26 - 35 | > 35 |
Key Summary
DACE | HLTH | |
|---|---|---|
Strategy | DACE.AX was created on 2006-07-03 by Dimensional. The fund's investment portfolio concentrates primarily on total market equity. The investment objective of the Fund is to provide long-term capital growth by gaining exposure to a diversified portfolio of securities listed in Australia with increased emphasis on higher expected return securities relative to a Market Capitalisation Weighted portfolio | HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars. |
Top 3 holdings | BHP Group Ltd (10.49 %) Commonwealth Bank of Australia (4.23 %) National Australia Bank Ltd (3.17 %) | Arrowhead Pharmaceuticals Inc (2.27 %) argenx SE ADR (2.27 %) UCB SA (2.20 %) |
Top 3 industries | Financials (40.36 %) Materials (26.23 %) Consumer Discretionary (7.34 %) | Health Care (100.00 %) Other (9.10 %) |
Top 3 countries | Australia (99.58 %) United States (0.39 %) New Zealand (0.02 %) | United States (65.74 %) Japan (10.95 %) Denmark (8.04 %) |
Management fee | 0.28 % | 0.45 % |
Key Summary
DACE | HLTH | |
|---|---|---|
Issuer | Dimensional | VanEck |
Tracking index | S&P/ASX 300 Index - AUD | MarketGrader Developed Markets ex-Australia Health Care Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.28 % | 0.45 % |
Price | $18.69 | $11.29 |
Size | N/A | $50.281 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 2.64 % | 0.61 % |
Market | ASX | ASX |
First listed date | 12/11/2023 | 09/09/2020 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DACE | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 19 | 54 |
Median incremental investment | $2,446.75 | $547.55 |
Median investment frequency | Monthly | Monthly |
Median total investment | $10,858.89 | $1,541.09 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DACE | HLTH | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DACE | HLTH |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |